The Brazilian Health Regulatory Agency (Anvisa) on Sunday approved the use of two vaccines against the coronavirus disease, developed by compes AstraZeneca and Sinovac.
The decision is said to have been made at the regulator's meeting.
The experts noted the safety and effectiveness of those vaccines and requested the compes to continue providing information to Anvisa.
Earlier, the regulator refused to grant Brazilian pharmaceutical company Uniao Quimica authorization for the emergency use of Russia's Sputnik V vaccine. (/Sputnik)
( With inputs from ANI )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor